Broadwood Partners, L.P. Oncocyte Corp (OCX) insider trading activity

Broadwood Partners, L.P. is > 10% Shareholder of Oncocyte Corp. Currently has a direct ownership of 4.93 Million shares of OCX, which is worth approximately $14.2 Million. The most recent transaction as insider was on Apr 11, 2024, when has been sold 2,420,000 shares (Common Stock, No Par Value) at a price of $2.92 per share, resulting in proceeds of $7,066,400. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4.93M

0% 3M change

90.18% 12M change

Total Value Held $14.2 Million

BROADWOOD PARTNERS, L.P. Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 11 2024	BUY Open market or private purchase	$7,066,400 $2.92 p/Share	2,420,000 Added 32.93%	4,929,066 Common Stock, No Par V...
Apr 03 2023	BUY Open market or private purchase	$8,048,291 $0.3 p/Share	26,827,638 Added 34.84%	50,181,335 Common Stock, No Par V...
Apr 14 2022	BUY Open market or private purchase	$7,984,990 $1.33 p/Share	6,003,752 Added 20.45%	23,353,697 Common Stock, No Par V...
Sep 23 2021	BUY Exercise of in-the-money or at-the-money derivatives securities	$1,806,402 $3.15 p/Share	573,461 Added 3.2%	17,349,945 Common Stock, No Par V...
Feb 05 2021	BUY Open market or private purchase	$2,700,000 $4.5 p/Share	600,000 Added 3.45%	16,776,484 Common Stock, No Par V...
Jan 20 2021	BUY Open market or private purchase	$4,994,158 $3.42 p/Share	1,460,280 Added 8.28%	16,176,484 Common Stock, No Par V...
Apr 24 2020	BUY Open market or private purchase	$2,383,500 $2.27 p/Share	1,050,000 Added 6.66%	14,716,204 Common Stock, No Par V...
Jan 02 2020	BUY Open market or private purchase	$3,005,567 $2.16 p/Share	1,391,466 Added 9.24%	13,666,204 Common Stock, No Par V...
Nov 13 2019	BUY Open market or private purchase	$2,000,001 $1.7 p/Share	1,176,471 Added 8.75%	12,274,738 Common Stock, No Par V...
Sep 11 2019	BUY Open market or private purchase	$3,320,000 $1.66 p/Share	2,000,000 Added 15.27%	11,098,267 Common Stock, No Par V...
Jul 02 2019	BUY Open market or private purchase	$2,000,000 $2.0 p/Share	1,000,000 Added 9.9%	9,098,267 Common Stock, No Par V...
Feb 08 2019	BUY Open market or private purchase	$1,999,999 $3.75 p/Share	533,333 Added 6.18%	8,098,267 Common Stock, No Par V...
Mar 28 2018	BUY Open market or private purchase	$5,000,000 $1.26 p/Share	3,968,254 Added 34.41%	7,564,934 Common Stock, No Par V...

Also insider at

LCTX

Lineage Cell Therapeutics, Inc. Healthcare

Director

CMRO

COMARCO INC

> 10% Shareholder

STAA

STAAR SURGICAL CO Healthcare

> 10% Shareholder

BPL